---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-24-000755"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:23:53.536188+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# IGC Pharma extends loan agreement with O-Bank; facility fees cut to $84,000 from $120,000

## Summary
- Extension effective July 8, 2024, extends term of existing Master Loan and Security Agreement under same terms.
- Facility fees reduced to $84,000 from $120,000; no other material changes to the agreement.
- The loan agreement was previously disclosed in July 2023 8-K; this amendment solely extends the term.
- No new borrowing or change in principal amount; obligation remains under existing credit facility.

## SEC filing metadata
- accession: 0001185185-24-000755
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000755/0001185185-24-000755-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000755/igc20240802_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-24-000755
- JSON: https://secwatch.observer/filing/0001185185-24-000755.json
- Plain text: https://secwatch.observer/filing/0001185185-24-000755.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.